No 3.17 (2016)

Table of Contents

Cover story

Intravenous Iron Drugs Usage in the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease PDF (Русский)
D.D. Ivanov, Ya.A. Dombrowski 9-13

Original Articles

Hypomagnesemia in Chronic Kidney Disease: Problem or Individual Characteristics of Certain Patients? PDF (Українська)
L.M. Savytska 21-24
Effectiveness of pantocrinum in the complex treatment of chronic kidney disease PDF (Українська)
N.O. Kolomiychuk 25-28
Effect of Albuminuria on the State of Plasma Hemostasis in Patients with Essential Hypertension PDF (Українська)
A.I. Pastushyna, O.M. Plenova 29-33

Guidelines

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice PDF (Українська) PDF
Ron T. Gansevoort, Mustafa Arici, Thomas Benzing 34-38
National Guidelines «Acute Kidney Injury: Basic Principles of the Diagnosis, Prevention and Treatment (2015)» Part II PDF (Русский)
A.V. Smirnov, V.A. Dobronravov 39-52
KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update PDF (Русский) PDF
by National Kidney Foundation, transl. Dmytro D. Ivanov 53-56

Lecture

Hemostatic System and its Regulation in Disorders of Renal Function PDF (Русский)
O.O. Melnyk 57-75

Clinical Observation

Ciliopathies, the Role of Wnt-Signaling Pathway in the Course of Acute (Postinfectious) Glomerulonephritis: Literature Review and Own Observations PDF (Українська)
O.O. Diadyk, L.H. Nekrasova, M.D. Ivanova 77-85